New Scandal in Pharma: Decisions are made quiet, win – manufacturers “Darnitsa” and “Intechim”
Everything went to transparent reform. For two months, the expert group worked on the document, discussed, agreed with all market participants. But a few hours before the key meeting, the MoH suddenly “rolled” a completely different text.
At the meeting, everyone spoke against this document – except for two players who are profitable: Darnitsa and Intechim.
And if you look deeper – as the stopper did – it becomes clear: everything was well prepared. Darnitsa publicly reports on “price reduction”. And so, they really fell – but only a few packing, such as “Ibuprofen 50 tablets” or “Citramon 6 pieces”. And before that, these same drugs went up exactly to the same 30%. That is, first – sharp growth and then beautiful “decrease”.
In parallel Darnytsia raised prices by 120% during the war And part of it was written off for marketing. It is the marketing that was now removed, leaving the money.
And who won in this story? Let's say so – not patients.
🎥 Details – In the StopCor Investigation: https://youtu.be/o2ugiwvhbqy
DUST⚡️Ukraine | Send the news
Who actually earned the checkery of medicines? | StopCor
📍 Become a sponsor of this channel to support us and receive bonuses:
https://www.youtube.com/channel/ucv-cru5zjyoh_5onvkauwg/join
In early February, the President personally spread the campaign to reduce the cost of drugs for Ukrainians. This idea was gladly picked up …
